Cooley adds Mintz Levin life sciences patent team

Managing IP is part of Legal Benchmarking Limited, 4 Bouverie Street, London, EC4Y 8AX

Copyright © Legal Benchmarking Limited and its affiliated companies 2024

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

Cooley adds Mintz Levin life sciences patent team

Cooley has added a life sciences patent team led by Ivor Elrifi, the former co-chair of Mintz Levin’s IP practice, and fellow former Mintz Levin partner Heidi Erlacher

ivor20elrifi20heidi20erlacher.jpg

Elrifi, Erlacher and their team will be based in Cooley’s Boston and New York offices. Four former Mintz Levin partners are joining Elrifi and Erlacher at Cooley.

Elrifi has advised companies around the world in various industries, including pharmaceutical, biotechnology and life sciences, on developing patent strategies and in the prosecution, licensing and enforcement of patents.

Erlacher advises clients on patent strategy, counseling and prosecution for life sciences companies, including pharmaceutical companies, in areas such as chemistry, biochemistry and biotechnology.

 

more from across site and ros bottom lb

More from across our site

Sapna Palla, who joins the firm from A&O Shearman, said she was impressed by its work with major life sciences businesses
The court’s decision will have brands and their advisers ‘desperately reviewing’ portfolios and filing strategies, sources predict
Simona Lavagnini discusses the Greek classics, Rudyard Kipling's 'If', and how she dreams of beautiful words
Herbert Smith Freehills and Kramer Levin’s merger won’t be the last transatlantic tie-up if recent history is anything to go by
Betty Chen reveals litigation opportunities and provides an update on plans to double the firm's headcount in San Francisco
David Parrish expects AI to be among the major talking points for a newly formed committee aimed at protecting the interests of London-based IP practitioners, firms, and their clients
The court, which revealed that the parties had settled their dispute, also upheld findings of infringement
Wu Xiaoping of Wanhuida Intellectual Property says the methodology often applied in assessing inventiveness in pharmaceutical patent litigation cases is set to be used in re-examination and invalidation proceedings after the CNIPA makes an invalidation decision a quasi-precedent
Exclusive data and in-house analysis show that law firms should work smarter, not harder, to ensure their communication has greater impact on clients
The tie-up, which will create a firm with a combined revenue of around $2bn, will add around 10 US-based partners to Herbert Smith Freehills’s IP offering
Gift this article